Exact FDA event identifier

Event 92977

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: August 29, 2023
Product types: Drug
Classifications: Class III
Statuses: Terminated
Recalling firm wording: RB Health (US) LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90

D-1179-2023

Recall number: D-1179-2023
Initiated: August 29, 2023
Classification: Class III
Status: Terminated
Recalling firm: RB Health (US) LLC
Quantity: 6,072 cases/36,426 individual selling units

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

Labeling: Label Error

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.

Code information

Lot # KT220211, Exp 07/2024

Distribution pattern

USA nationwide